- Home
- PRGO vs RVNC Comparison
PRGO vs RVNC Comparison
Compare PRGO & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- RVNC
- Stock Information
- Founded
- PRGO 1887
- RVNC 1999
- Country
- PRGO Ireland
- RVNC United States
- Employees
- PRGO N/A
- RVNC N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- PRGO Health Care
- RVNC Health Care
- Exchange
- PRGO Nasdaq
- RVNC Nasdaq
- Market Cap
- PRGO 3.9B
- RVNC 320.5M
- IPO Year
- PRGO 1991
- RVNC 2014
- Fundamental
- Price
- PRGO $25.76
- RVNC $3.09
- Analyst Decision
- PRGO Buy
- RVNC Hold
- Analyst Count
- PRGO 4
- RVNC 9
- Target Price
- PRGO $37.00
- RVNC $8.45
- AVG Volume (30 Days)
- PRGO 1.2M
- RVNC 3.6M
- Earning Date
- PRGO 11-06-2024
- RVNC 11-07-2024
- Dividend Yield
- PRGO 4.29%
- RVNC N/A
- EPS Growth
- PRGO N/A
- RVNC N/A
- EPS
- PRGO N/A
- RVNC N/A
- Revenue
- PRGO $4,392,000,000.00
- RVNC $256,945,000.00
- Revenue This Year
- PRGO N/A
- RVNC $11.28
- Revenue Next Year
- PRGO $4.51
- RVNC $27.21
- P/E Ratio
- PRGO N/A
- RVNC N/A
- Revenue Growth
- PRGO N/A
- RVNC 25.82
- 52 Week Low
- PRGO $23.89
- RVNC $2.30
- 52 Week High
- PRGO $34.60
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- PRGO 36.42
- RVNC 33.47
- Support Level
- PRGO $25.16
- RVNC $3.06
- Resistance Level
- PRGO $28.62
- RVNC $3.09
- Average True Range (ATR)
- PRGO 0.66
- RVNC 0.11
- MACD
- PRGO -0.35
- RVNC 0.02
- Stochastic Oscillator
- PRGO 15.79
- RVNC 6.90
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.